0,874  0,007  Antiinflammatory
0,822  0,006  CYP2C9 substrate
0,769  0,005  CYP2C19 substrate
0,754  0,005  Antiepileptic
0,768  0,020  Apoptosis agonist
0,704  0,004  UGT1A4 substrate
0,702  0,004  Carcinogenic, group 3
0,709  0,015  Teratogen
0,702  0,015  Embryotoxic
0,686  0,004  Antineoplastic (endocrine cancer)
0,680  0,006  AR expression inhibitor
0,693  0,021  Antineoplastic (breast cancer)
0,670  0,022  Antineoplastic (lung cancer)
0,650  0,008  Cardiovascular analeptic
0,646  0,013  Chemoprotective
0,639  0,010  Antineoplastic (cervical cancer)
0,621  0,003  Pneumotoxic
0,619  0,003  Vanilloid agonist
0,627  0,015  Respiratory analeptic
0,600  0,011  Antineoplastic (pancreatic cancer)
0,614  0,027  CYP3A4 substrate
0,601  0,015  Antineoplastic (ovarian cancer)
0,586  0,007  UGT1A1 substrate
0,596  0,018  Carcinogenic
0,588  0,015  Immunosuppressant
0,585  0,014  Antineoplastic (melanoma)
0,562  0,012  Nitric oxide antagonist
0,551  0,010  Skin irritative effect
0,566  0,027  Antineoplastic (colorectal cancer)
0,538  0,002  UGT2B9 substrate
0,550  0,027  Antineoplastic (colon cancer)
0,537  0,015  NOS2 expression inhibitor
0,531  0,010  UDP-glucuronosyltransferase substrate
0,537  0,020  Sensitization
0,547  0,032  GST A substrate
0,519  0,004  5 Hydroxytryptamine uptake stimulant
0,530  0,017  Proliferative diseases treatment
0,543  0,032  Antileukemic
0,515  0,004  UGT2B7 substrate
0,544  0,036  TNF expression inhibitor
0,510  0,004  Abortion inducer
0,541  0,039  Transcription factor NF kappa B inhibitor
0,525  0,023  Bone diseases treatment
0,520  0,020  Analeptic
0,502  0,004  Antiviral (Influenza A)
0,501  0,007  Sleep disorders treatment
0,508  0,017  Metabolic disease treatment
0,529  0,041  Analgesic
0,515  0,029  Prostate cancer treatment
0,509  0,030  Antipruritic, allergic
0,524  0,051  Caspase 9 stimulant
0,471  0,003  Alcohol dehydrogenase substrate
0,505  0,039  Antibacterial
0,466  0,005  Antiviral (Influenza)
0,462  0,005  Lipocortins synthesis antagonist
0,461  0,004  Expectorant
0,469  0,018  Antiparasitic
0,459  0,009  Melanin inhibitor
0,463  0,017  UGT2B4 substrate
0,466  0,025  Antiosteoporotic
0,461  0,022  Chemopreventive
0,456  0,031  Antifungal
0,438  0,013  Antihelmintic
0,451  0,028  CTGF expression inhibitor
0,431  0,010  Hair growth stimulant
0,427  0,011  Contraceptive
0,453  0,039  Mood disorders treatment
0,416  0,010  Antihypotensive
0,411  0,009  Antipruritic, non-allergic
0,422  0,033  NOS3 expression inhibitor
0,391  0,004  Posttraumatic stress disorder treatment
0,388  0,005  Autism spectrum disorders treatment
0,394  0,011  Antiacne
0,418  0,038  Hepatic disorders treatment
0,398  0,022  DNA synthesis inhibitor
0,395  0,023  Angiogenesis stimulant
0,391  0,020  Sedative
0,394  0,027  Calcium channel activator
0,423  0,060  Antiprotozoal
0,392  0,031  Mutagenic
0,399  0,044  CYP2D6 substrate
0,399  0,045  FMO1 substrate
0,389  0,037  Antioxidant
0,385  0,035  Cytostatic
0,374  0,026  Dependence treatment
0,378  0,035  Antiprotozoal (Leishmania)
0,358  0,023  Eye irritation, high
0,366  0,031  Antineoplastic (osteosarcoma)
0,337  0,002  Ca(v)3.1 blocker
0,381  0,048  Antihypercholesterolemic
0,338  0,007  Antifungal enhancer
0,347  0,022  Antiviral (HIV)
0,337  0,016  Antialcoholic
0,388  0,069  CYP2C19 inhibitor
0,324  0,004  Movement disorders treatment
0,356  0,036  Sodium/bile acid cotransporter inhibitor
0,361  0,041  Cytotoxic
0,320  0,004  Vanilloid 1 agonist
0,315  0,005  Choleretic
0,323  0,018  Anesthetic
0,329  0,026  Muscle relaxant
0,314  0,015  CYP2B6 inhibitor
0,300  0,004  GABA C receptor antagonist
0,315  0,021  VCAM1 expression inhibitor
0,360  0,067  Antiprotozoal (Plasmodium)
0,339  0,046  Antineurogenic pain
0,296  0,004  Aldehyde dehydrogenase substrate
0,306  0,016  Protein kinase stimulant
0,328  0,039  Vasodilator
0,308  0,021  Antineoplastic (carcinoma)
0,322  0,037  Psychostimulant
0,347  0,065  Cholesterol antagonist
0,353  0,071  Inflammatory Bowel disease treatment
0,382  0,101  Antidiabetic
0,382  0,101  Cyclophilin D inhibitor
0,299  0,020  Interferon gamma antagonist
0,370  0,093  Antiparkinsonian
0,320  0,045  Antidiabetic symptomatic
0,282  0,011  Antineoplastic antibiotic
0,288  0,019  UGT2B15 substrate
0,308  0,042  GST M1-1 substrate
0,270  0,005  Mucolytic
0,349  0,086  GABA C receptor rho-3 antagonist
0,270  0,008  Antispirochetal
0,295  0,034  Anesthetic general
0,308  0,048  Antineoplastic (liver cancer)
0,327  0,068  Apoptosis antagonist
0,287  0,030  Peptidyltransferase inhibitor
0,306  0,051  Tumour necrosis factor alpha release inhibitor
0,279  0,026  Antiviral (Herpes)
0,298  0,050  Antiglaucomic
0,282  0,035  Hepatoprotectant
0,304  0,057  Antineoplastic (glioma)
0,259  0,019  Succinate dehydrogenase inhibitor
0,245  0,007  Arachidonic acid antagonist
0,295  0,057  Flavin-containing monooxygenase substrate
0,267  0,030  Neurotrophic factor enhancer
0,241  0,011  Microtubule formation inhibitor
0,235  0,010  Androgen antagonist
0,239  0,016  UGT2B10 substrate
0,227  0,008  Antineoplastic alkaloid
0,273  0,055  Antineoplastic (glioblastoma multiforme)
0,217  0,008  Actinic keratosis treatment
0,244  0,035  Antiviral (Hepatitis)
0,234  0,027  Antiviral (Hepatitis C)
0,283  0,077  Spasmolytic
0,263  0,057  Tyrosine 3 hydroxylase inhibitor
0,252  0,048  RNA-directed DNA polymerase inhibitor
0,211  0,009  TRPA1 agonist
0,220  0,020  Antirickettsial
0,216  0,018  GABA C receptor agonist
0,263  0,067  Myocardial infarction treatment
0,210  0,014  Menstruation disorders treatment
0,199  0,004  UGT2B11 substrate
0,220  0,025  Cocaine dependence treatment
0,230  0,037  Acaricide
0,198  0,005  Antiprotozoal activity enhancer
0,256  0,063  Antineoplastic (sarcoma)
0,209  0,019  Carcinogenic, group 2B
0,272  0,083  CYP1A2 substrate
0,269  0,081  5 Hydroxytryptamine release stimulant
0,217  0,030  Alpha-N-acetylglucosaminidase inhibitor
0,190  0,005  Anabolic
0,208  0,024  Alkylator
0,275  0,093  Caspase 3 stimulant
0,194  0,012  Antiviral (Influenza B)
0,185  0,005  Ca2+-transporting ATPase inhibitor
0,222  0,043  Antianorexic
0,193  0,015  Contraceptive female
0,212  0,034  Interleukin 6 antagonist
0,208  0,031  ATPase inhibitor
0,178  0,004  Glycine receptor antagonist
0,260  0,090  Antineoplastic (multiple myeloma)
0,235  0,069  UGT1A6 substrate
0,204  0,040  Toxic, respiratory center
0,175  0,011  Antiprotozoal (Toxoplasma)
0,257  0,094  Hypoxia-inducible factor 1 alpha inhibitor
0,185  0,022  Adenylate cyclase stimulant
0,197  0,037  Genotoxic
0,197  0,038  Skin whitener
0,165  0,006  Androgen agonist
0,263  0,105  Immunomodulator
0,181  0,025  Endometrios treatment
0,179  0,025  Growth stimulant
0,246  0,092  Lipoprotein disorders treatment
0,238  0,087  Aldehyde oxidase inhibitor
0,163  0,012  SULT1E1 substrate
0,260  0,109  Antineoplastic (brain cancer)
0,163  0,013  Transcription factor NF kappa B stimulant
0,158  0,009  Antihypermotility
0,263  0,116  Antithrombotic
0,188  0,042  Carcinogenic, group 1
0,200  0,054  Antimutagenic
0,149  0,005  Aldosterone antagonist
0,271  0,128  Cognition disorders treatment
0,176  0,034  Cholesterol synthesis inhibitor
0,175  0,033  Antieczematic
0,172  0,031  GST P1-1 substrate
0,194  0,053  Antihelmintic (Nematodes)
0,147  0,007  5-Alpha-reductase inhibitor
0,257  0,119  ICAM1 expression inhibitor
0,245  0,107  FMO3 substrate
0,156  0,020  Prolactin inhibitor
0,237  0,102  Immunostimulant
0,174  0,039  Monophenol monooxygenase inhibitor
0,163  0,030  SULT1A1 substrate
0,211  0,079  Antiparkinsonian, rigidity relieving
0,186  0,054  Prostate disorders treatment
0,182  0,051  Uterine stimulant
0,148  0,020  Antibiotic
0,142  0,015  Antiviral (Rhinovirus)
0,237  0,111  Antihypoxic
0,143  0,017  Contraceptive male
0,134  0,010  Na+ K+ transporting ATPase inhibitor
0,181  0,059  Aldehyde oxidase substrate
0,168  0,046  Antianemic
0,164  0,042  Antifungal (Cryptococcus)
0,176  0,055  Acute respiratory distress syndrome (ARDS) treatment
0,222  0,103  UGT1A9 substrate
0,137  0,019  Antiviral (Trachoma)
0,139  0,022  Antiviral (Coronavirus)
0,139  0,022  Antiviral (SARS coronavirus)
0,153  0,035  Antiviral (Poxvirus)
0,152  0,037  Ferrochelatase inhibitor
0,182  0,068  Sigma receptor agonist
0,166  0,052  Antiprotozoal (Coccidial)
0,177  0,064  UGT1A3 substrate
0,171  0,058  Acetylcholine M1 receptor antagonist
0,148  0,035  Shock treatment
0,167  0,055  Antineoplastic (squamous cell carcinoma)
0,212  0,102  Hypoglycemic
0,192  0,082  Insulin sensitizer
0,131  0,021  Inducible nitric-oxide synthase inhibitor
0,123  0,015  Premenstrual syndrome treatment
0,116  0,008  Vanilloid 4 agonist
0,137  0,030  Estrogen antagonist
0,203  0,095  Free radical scavenger
0,153  0,046  Antihyperlipoproteinemic
0,111  0,004  Anesthetic inhalation
0,126  0,021  Glutamate dehydrogenase inhibitor
0,173  0,069  Prostatic (benign) hyperplasia treatment
0,135  0,031  Electron transport complex I inhibitor
0,118  0,015  Postmenopausal disorders treatment
0,178  0,076  Diabetic retinopathy treatment
0,137  0,034  Sulfotransferase substrate
0,223  0,123  Antipsoriatic
0,218  0,119  Radiosensitizer
0,138  0,039  Photosensitizer
0,159  0,061  Antiparkinsonian, tremor relieving
0,159  0,061  CF transmembrane conductance regulator agonist
0,103  0,005  Postcoital contraceptive
0,222  0,124  Antidepressant
0,156  0,059  CNS active muscle relaxant
0,134  0,037  Antineoplastic, alkylator
0,156  0,059  SULT1A3 substrate
0,099  0,004  Pregnane X receptor antagonist
0,124  0,028  Estrogen receptor beta antagonist
0,107  0,012  Antitreponemal
0,112  0,017  T cell inhibitor
0,145  0,050  Proteasome inhibitor
0,097  0,003  Kainate receptor agonist
0,194  0,100  Nitric-oxide synthase stimulant
0,168  0,075  Phospholipase C inhibitor
0,109  0,018  Narcotic antagonist
0,241  0,150  Ulceration
0,099  0,009  SULT2A1 substrate
0,116  0,026  Phosphofructokinase-1 inhibitor
0,124  0,035  GST T1-1 substrate
0,120  0,032  Triose-phosphate isomerase inhibitor
0,095  0,007  Andropause treatment
0,142  0,054  Topoisomerase II inhibitor
0,138  0,051  Coagulant
0,152  0,064  Cell wall synthesis inhibitor
0,103  0,016  Anticholelithogenic
0,100  0,013  Antimycoplasmal
0,183  0,096  Antihypertriglyceridemic
0,139  0,053  Antiviral (Hepatitis B)
0,098  0,012  Hypercalcemia treatment
0,114  0,029  CYP2A6 inhibitor
0,115  0,031  Antidote, mercury
0,132  0,049  Topoisomerase I inhibitor
0,100  0,017  Estrogen agonist
0,102  0,019  Glycine receptor agonist
0,171  0,089  P-glycoprotein inhibitor
0,095  0,014  Protein 50S ribosomal subunit inhibitor
0,113  0,033  Topoisomerase II alpha inhibitor
0,127  0,049  Antiviral (CMV)
0,081  0,005  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,142  0,066  Bone formation stimulant
0,192  0,117  Antineoplastic (renal cancer)
0,097  0,024  HIV-1 integrase (Strand Transfer) inhibitor
0,080  0,007  Glucocorticoid antagonist
0,077  0,005  GABA uptake inhibitor
0,088  0,017  Glutamate (mGluR6) antagonist
0,119  0,049  UGT2B1 substrate
0,073  0,004  Vanilloid 3 antagonist
0,119  0,050  AMP-activated protein kinase stimulant
0,077  0,008  Retinoid X receptor agonist
0,090  0,022  Adrenaline uptake inhibitor
0,081  0,013  Lipocortins synthesis agonist
0,115  0,048  Adenylate kinase inhibitor
0,108  0,040  Paget's disease treatment
0,072  0,006  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,115  0,050  Beta glucuronidase inhibitor
0,110  0,046  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,079  0,016  Sphingosine kinase 2 inhibitor
0,065  0,002  Vanilloid 2 agonist
0,094  0,032  Estrogen receptor alpha antagonist
0,074  0,012  Progesterone antagonist
0,104  0,043  Carcinogenic, group 2A
0,067  0,007  Hypogonadism treatment
0,070  0,009  RNA-directed RNA polymerase stimulant
0,097  0,037  Porphobilinogen synthase inhibitor
0,069  0,010  TRPM8 blocker
0,072  0,013  Estrogen receptor alpha agonist
0,084  0,026  Aromatase inhibitor
0,072  0,016  Estrogen receptor beta agonist
0,087  0,031  HIV-1 integrase (3'-Processing) inhibitor
0,100  0,044  Ornithine decarboxylase inhibitor
0,067  0,012  Cholesterol esterase inhibitor
0,201  0,147  Gastrin inhibitor
0,074  0,021  Sphingosine kinase inhibitor
0,069  0,019  Ryanodine receptor antagonist
0,055  0,006  Tubulin agonist
0,118  0,069  Retinopathy treatment
0,084  0,037  MAP kinase kinase 7 inhibitor
0,104  0,057  Xanthine oxidase inhibitor
0,067  0,020  Dihydroorotate oxidase inhibitor
0,178  0,132  Vascular (periferal) disease treatment
0,116  0,071  Adenylate cyclase inhibitor
0,067  0,025  Cannabinoid CB2 receptor antagonist
0,060  0,018  Adenylate cyclase 1 inhibitor
0,087  0,046  Antiviral (Dengue virus)
0,114  0,073  Antineoplastic antimetabolite
0,069  0,029  Calcium channel P-type blocker
0,078  0,038  Dysmenorrhea treatment
0,057  0,018  Microtubule stabilization
0,062  0,024  Aconitate hydratase inhibitor
0,067  0,028  Fatty acid synthase inhibitor
0,071  0,032  Antiviral (Parainfluenza)
0,255  0,217  Autoimmune disorders treatment
0,045  0,007  Adenosine uptake inhibitor
0,070  0,032  Biliverdin reductase inhibitor
0,151  0,114  Phobic disorders treatment
0,050  0,014  Squalene synthetase inhibitor
0,096  0,061  Lanosterol 14 alpha demethylase inhibitor
0,099  0,064  Chronic obstructive bronchitis treatment
0,039  0,005  Glutamate (mGluR1) agonist
0,057  0,023  Potassium channel Kv1.3 blocker
0,110  0,077  Interleukin 8 antagonist
0,038  0,005  Hedgehog signaling activator
0,067  0,035  Transcription factor RelA inhibitor
0,052  0,020  Kainate receptor antagonist
0,110  0,078  Beta amyloid protein antagonist
0,118  0,086  Papain-like protease (SARS coronavirus) inhibitor
0,078  0,049  GABA aminotransferase inhibitor
0,141  0,111  Hearing loss treatment
0,047  0,017  Kainate receptor 2 antagonist
0,113  0,084  Antifungal (Pneumocystis)
0,058  0,029  Nicotinic alpha3beta2 receptor antagonist
0,060  0,033  Acyl-CoA dehydrogenase inhibitor
0,142  0,115  3C-like protease (Human coronavirus) inhibitor
0,067  0,040  Interferon inducer
0,063  0,036  Dopamine uptake inhibitor
0,053  0,028  HCV NS3/NS4A protease inhibitor
0,125  0,099  Skeletal muscle relaxant
0,130  0,105  GABA C receptor rho-2 antagonist
0,120  0,095  Neurotrophic factor
0,117  0,093  Interleukin 1 antagonist
0,045  0,020  Membrane dipeptidase inhibitor
0,098  0,074  Toll-Like receptor 4 antagonist
0,059  0,035  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,095  0,072  Glutathione S-transferase substrate
0,028  0,005  Progesterone receptor B antagonist
0,051  0,028  Glucose-6-phosphate isomerase inhibitor
0,060  0,037  Calcium channel T-type blocker
0,155  0,132  Hypolipemic
0,040  0,018  Antihyperaldosteronism
0,062  0,041  Carbamoyl phosphate synthetase inhibitor
0,081  0,060  CC chemokine 5 receptor agonist
0,040  0,020  Glutamate (mGluR3) antagonist
0,024  0,005  Antibiotic Anthracycline-like
0,093  0,074  GABA C receptor rho-1 antagonist
0,076  0,058  Interferon agonist
0,145  0,126  Antimitotic
0,030  0,012  Retinoid X gamma receptor antagonist
0,050  0,032  Antiviral (Herpesvirus 3, Human)
0,108  0,091  Cyclooxygenase 3 inhibitor
0,025  0,010  Vitamin D receptor antagonist
0,066  0,051  MDM2 inhibitor
0,087  0,072  Obsessive-compulsive disorder treatment
0,023  0,009  Retinoid X beta receptor antagonist
0,023  0,009  Progesterone agonist
0,053  0,039  Alpha-mannosidase inhibitor
0,040  0,027  AMPA 4 receptor antagonist
0,042  0,028  Sphingosine kinase 1 inhibitor
0,088  0,076  UDP-glucose 4-epimerase inhibitor
0,088  0,077  Electrolyte absorption antagonist
0,023  0,012  Corticosteroid-like
0,028  0,017  Nicotinic acid receptor 2 antagonist
0,025  0,014  Retinoic acid receptor agonist
0,057  0,047  TRPA1 antagonist
0,094  0,084  GABA receptor agonist
0,118  0,108  Diuretic
0,019  0,009  Telomerase stimulant
0,035  0,026  Antibiotic Aminoglycoside-like
0,021  0,012  Antibiotic Quinolone-like
0,039  0,032  Estradiol 17 beta-dehydrogenase inhibitor
0,038  0,030  Retinoic acid alpha receptor agonist
0,032  0,024  Glutamate (mGluR3) agonist
0,033  0,026  Retinoid X alpha receptor agonist
0,017  0,011  Vitamin D receptor agonist
0,123  0,117  Sphingosine 1-phosphate receptor 5 antagonist
0,051  0,046  Argininosuccinate synthase inhibitor
0,015  0,010  Antibiotic Tetracycline-like
0,036  0,031  Retinoid X receptor antagonist
0,115  0,110  Sphingosine 1-phosphate receptor 2 antagonist
0,070  0,065  Keratolytic
0,074  0,070  Antidote, organophosphates
0,032  0,028  Retinoid X alpha receptor antagonist
0,036  0,032  Glutamate (mGluR8) agonist
0,021  0,018  Retinoic acid gamma receptor agonist
0,021  0,018  Retinoid X gamma receptor agonist
0,071  0,067  Acetylcholine nicotinic antagonist
0,021  0,018  Prostaglandin F2 alpha agonist
0,035  0,033  Vesicle monoamine transporter inhibitor
0,018  0,015  5-Alpha-reductase 2 inhibitor
0,062  0,060  Gaucher disease treatment
0,006  0,004  Transcortin receptor antagonist
0,064  0,063  Glutamate decarboxylase inhibitor
0,013  0,011  Antibiotic Macrolide-like
0,009  0,007  Progesterone receptor A antagonist
0,022  0,020  Protein 30S ribosomal subunit inhibitor
0,094  0,093  DNA polymerase I inhibitor
0,011  0,010  Glucocorticoid agonist
0,164  0,163  Radioprotector
0,020  0,019  Neuraminidase (Influenza B) inhibitor
0,093  0,092  DOPA decarboxylase inhibitor

